These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32959256)

  • 1. Flavivirus DNA Vaccine Design and Adjuvant Selection.
    Li L; Honda-Okubo Y; Petrovsky N
    Methods Mol Biol; 2021; 2183():405-422. PubMed ID: 32959256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Variable effects of the co-administration of a GM-CSF-expressing plasmid on the immune response to flavivirus DNA vaccines in mice.
    Chen H; Gao N; Wu J; Zheng X; Li J; Fan D; An J
    Immunol Lett; 2014 Nov; 162(1 Pt A):140-8. PubMed ID: 25128840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A single-dose plasmid-launched live-attenuated Zika vaccine induces protective immunity.
    Zou J; Xie X; Luo H; Shan C; Muruato AE; Weaver SC; Wang T; Shi PY
    EBioMedicine; 2018 Oct; 36():92-102. PubMed ID: 30201444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral Vaccination with a DNA Vaccine Encoding Capsid Protein of Duck Tembusu Virus Induces Protection Immunity.
    Huang J; Shen H; Jia R; Wang M; Chen S; Zhu D; Liu M; Zhao X; Yang Q; Wu Y; Liu Y; Zhang L; Yin Z; Jing B; Cheng A
    Viruses; 2018 Apr; 10(4):. PubMed ID: 29642401
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination with single plasmid DNA encoding IL-12 and antigens of severe fever with thrombocytopenia syndrome virus elicits complete protection in IFNAR knockout mice.
    Kang JG; Jeon K; Choi H; Kim Y; Kim HI; Ro HJ; Seo YB; Shin J; Chung J; Jeon YK; Kim YS; Lee KH; Cho NH
    PLoS Negl Trop Dis; 2020 Mar; 14(3):e0007813. PubMed ID: 32196487
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of immunogenicity and protective efficacy of a CpG-adjuvanted DNA vaccine against Tembusu virus.
    Chen H; Yan M; Tang Y; Diao Y
    Vet Immunol Immunopathol; 2019 Dec; 218():109953. PubMed ID: 31590073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The genetic adjuvant IL-12 enhances the protective efficacy of a DNA vaccine for Venezuelan equine encephalitis virus delivered by intramuscular injection in mice.
    Suschak JJ; Bagley K; Six C; Shoemaker CJ; Kwilas S; Spik KW; Dupuy LC; Schmaljohn CS
    Antiviral Res; 2018 Nov; 159():113-121. PubMed ID: 30268913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cross-Protection against MERS-CoV by Prime-Boost Vaccination Using Viral Spike DNA and Protein.
    Choi JA; Goo J; Yang E; Jung DI; Lee S; Rho S; Jeong Y; Park YS; Park H; Moon YH; Park U; Seo SH; Lee H; Lee JM; Cho NH; Song M; Kim JO
    J Virol; 2020 Nov; 94(24):. PubMed ID: 32967955
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Envelope-Modified Tetravalent Dengue Virus-Like-Particle Vaccine Has Implications for Flavivirus Vaccine Design.
    Urakami A; Ngwe Tun MM; Moi ML; Sakurai A; Ishikawa M; Kuno S; Ueno R; Morita K; Akahata W
    J Virol; 2017 Dec; 91(23):. PubMed ID: 28956764
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput neutralization assay for multiple flaviviruses based on single-round infectious particles using dengue virus type 1 reporter replicon.
    Matsuda M; Yamanaka A; Yato K; Yoshii K; Watashi K; Aizaki H; Konishi E; Takasaki T; Kato T; Muramatsu M; Wakita T; Suzuki R
    Sci Rep; 2018 Nov; 8(1):16624. PubMed ID: 30413742
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Hepatitis C Virus DNA Vaccine Encoding a Secreted, Oligomerized Form of Envelope Proteins Is Highly Immunogenic and Elicits Neutralizing Antibodies in Vaccinated Mice.
    Masavuli MG; Wijesundara DK; Underwood A; Christiansen D; Earnest-Silveira L; Bull R; Torresi J; Gowans EJ; Grubor-Bauk B
    Front Immunol; 2019; 10():1145. PubMed ID: 31178869
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A DNA vaccine encoding the E protein of West Nile virus is protective and can be boosted by recombinant domain DIII.
    Schneeweiss A; Chabierski S; Salomo M; Delaroque N; Al-Robaiy S; Grunwald T; Bürki K; Liebert UG; Ulbert S
    Vaccine; 2011 Aug; 29(37):6352-7. PubMed ID: 21596075
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Strong HCV NS3/4a, NS4b, NS5a, NS5b-specific cellular immune responses induced in Rhesus macaques by a novel HCV genotype 1a/1b consensus DNA vaccine.
    Latimer B; Toporovski R; Yan J; Pankhong P; Morrow MP; Khan AS; Sardesai NY; Welles SL; Jacobson JM; Weiner DB; Kutzler MA
    Hum Vaccin Immunother; 2014; 10(8):2357-65. PubMed ID: 25424943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chimeric flaviviruses: novel vaccines against dengue fever, tick-borne encephalitis, and Japanese encephalitis.
    Lai CJ; Monath TP
    Adv Virus Res; 2003; 61():469-509. PubMed ID: 14714441
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Multiagent Alphavirus DNA Vaccine Delivered by Intramuscular Electroporation Elicits Robust and Durable Virus-Specific Immune Responses in Mice and Rabbits and Completely Protects Mice against Lethal Venezuelan, Western, and Eastern Equine Encephalitis Virus Aerosol Challenges.
    Dupuy LC; Richards MJ; Livingston BD; Hannaman D; Schmaljohn CS
    J Immunol Res; 2018; 2018():8521060. PubMed ID: 29967804
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flavivirus immunization with capsid-deletion mutants: basics, benefits, and barriers.
    Mandl CW
    Viral Immunol; 2004; 17(4):461-72. PubMed ID: 15671744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA Vaccines - A Modern Gimmick or a Boon to Vaccinology?
    Manickan E; Karem KL; Rouse BT
    Crit Rev Immunol; 2017; 37(2-6):483-498. PubMed ID: 29773031
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of Virus-Like-Particle Vaccine and Reporter Assay for Zika Virus.
    Garg H; Sedano M; Plata G; Punke EB; Joshi A
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794019
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of the RepliVax platform for replication-defective flavivirus vaccines.
    Rumyantsev AA; Giel-Moloney M; Liu Y; Gao QS; Zhang ZX; Catalan J; Frolov I; Almond J; Kleanthous H; Pugachev KV
    Vaccine; 2011 Jul; 29(32):5184-94. PubMed ID: 21620917
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic Herpes Simplex Virus 2 (HSV-2) Vaccines Adjuvanted with Stable Emulsion and Toll-Like Receptor 9 Agonist Induce a Robust HSV-2-Specific Cell-Mediated Immune Response, Protect against Symptomatic Disease, and Reduce the Latent Viral Reservoir.
    Hensel MT; Marshall JD; Dorwart MR; Heeke DS; Rao E; Tummala P; Yu L; Cohen GH; Eisenberg RJ; Sloan DD
    J Virol; 2017 May; 91(9):. PubMed ID: 28228587
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.